SAMANTHA FRAZIER: Open Payments
NPI 1427487784 · HANOVER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 6 payments from 6 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: Wegovy, ELIQUIS, SHINGRIX, Kerendia, REXULTI, LEQVIO.
Industry payments across MD — which companies pay providers there.
